Ivermectin does not reduce risk of COVID-19 illness - MOH
Based on the outcomes of the I-TECH study by the Institute for Clinical Research (ICR), Ivermectin cannot be recommended for inclusion in the current COVID-19 treatment guidelines.
Wed Nov 03 2021
![[PODCAST] Daily Dose @ 5: Sinovac COVID jab highly effective against serious illness, More than half of Australia's adults fully inoculated](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-09/71600683822_DailyDose.jpg "[PODCAST] Daily Dose @ 5: Sinovac COVID jab highly effective against serious illness, More than half of Australia's adults fully inoculated")
[PODCAST] Daily Dose @ 5: Sinovac COVID jab highly effective against serious illness, More than half of Australia's adults fully inoculated
Catch up on the top stories of the day, in just 3-minutes!
Fri Sep 24 2021
MOH starts Ivermectin trial for high risk COVID-19 patients - Health D-G
The MOH and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk COVID-19 patients at 12 MOH hospitals.
Sat Jun 05 2021